Swiss National Bank’s iRadimed IRMD Stock Holding History

Swiss National Bank’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	16,700 +400	+2%	+$36.4K	﹤0.01%	2045
2026 Q1	$1.57M	Hold	16,300	–	–	﹤0.01%	1969
2025 Q4	$1.59M	Buy	16,300 +500	+3%	+$42.9K	﹤0.01%	1974
2025 Q3	$1.12M	Hold	15,800	–	–	﹤0.01%	2116
2025 Q2	$945K	Buy	15,800 +800	+5%	+$43.8K	﹤0.01%	2168
2025 Q1	$787K	Hold	15,000	–	–	﹤0.01%	2235
2024 Q4	$825K	Hold	15,000	–	–	﹤0.01%	2288
2024 Q3	$754K	Hold	15,000	–	–	﹤0.01%	2328
2024 Q2	$659K	Sell	15,000 -1,200	-7%	-$51K	﹤0.01%	2349
2024 Q1	$713K	Buy	16,200 +1,300	+9%	+$57.5K	﹤0.01%	2369
2023 Q4	$707K	Sell	14,900 -1,700	-10%	-$71.5K	﹤0.01%	2402
2023 Q3	$737K	Buy	+16,600	New	+$771K	﹤0.01%	2395

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swiss National Bank's IRMD Position: Q2 2026 in Review

Swiss National Bank increased its iRadimed (IRMD) stake by 2.5% in Q2 2026, buying an estimated $36.4K and bringing the position to 16,700 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Swiss National Bank first reported a position in IRMD in Q3 2023 and has held it in 12 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Swiss National Bank held 16,700 shares of iRadimed worth $1.6M as of Q2 2026.
Swiss National Bank bought 400 iRadimed shares in Q2 2026, an estimated $36.4K.
iRadimed made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2045 holding.
Swiss National Bank first reported a position in iRadimed in Q3 2023 and has held it in 12 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.